Neutrophils

Neutrophils, a key component of the innate immune system, are believed to contribute to the inflammation and tissue damage seen in type 1 diabetes, though their exact role in disease onset and progression is still not fully understood. Recent studies suggest that neutrophils may interact with other immune cells, such as T cells, to amplify the autoimmune response against beta cells, but the mechanisms behind this interaction remain unclear. Key knowledge gaps include how neutrophils are activated in type 1 diabetes, their precise involvement in beta-cell destruction, and whether targeting neutrophil activity could offer therapeutic benefits in managing the disease.

Neutrophil Projects

9/1/2024
-
8/31/2028
Neutrophils and their role in type 1 diabetes

Promotors:

Chantal Mathieu

Conny Gysemans

Mateson Beya

1/1/2024
-
12/31/2026
Neutrophils: novel players in the initiation and execution of autoimmune type 1 diabetes?

Promotors:

Chantal Mathieu

1/1/2023
-
12/31/2026
Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuation

Promotors:

Chantal Mathieu

Conny Gysemans

10/1/2018
-
11/13/2023
Neutrophils and post-translationally modified beta-cell proteins: a driving force behind type 1 diabetes?

Promotors:

Chantal Mathieu

Lut Overbergh

Samal Bissenova

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.